Scott Cormack
2017
In 2017, Scott Cormack earned a total compensation of $317.9K as Former President and Chief Executive Officer at OncoGenex Pharmaceuticals, a 54% decrease compared to previous year.
Compensation breakdown
| Salary | $317,889 |
|---|---|
| Total | $317,889 |
Cormack received $317.9K in salary, accounting for 100% of the total pay in 2017.
Rankings
In 2017, Scott Cormack's compensation ranked 13,202nd out of 14,666 executives tracked by ExecPay. In other words, Cormack earned more than 10.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 13,202 out of 14,666 | 10th |
Division Manufacturing | 5,197 out of 5,772 | 10th |
Major group Chemicals And Allied Products | 1,885 out of 2,075 | 9th |
Industry group Drugs | 1,572 out of 1,731 | 9th |
Industry In Vitro and In Vivo Diagnostic Substances | 64 out of 72 | 11th |
Source: SEC filing on April 19, 2018.
Cormack's colleagues
We found four more compensation records of executives who worked with Scott Cormack at OncoGenex Pharmaceuticals in 2017.